<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04029142</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01065; sp19Amstad</org_study_id>
    <nct_id>NCT04029142</nct_id>
  </id_info>
  <brief_title>Screening for Hemoglobinopathies in Pregnant Women</brief_title>
  <official_title>Screening for Hemoglobinopathies in Pregnant Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective monocentric study project is to identify hemoglobinopathies in pregnant
      women in order to optimize antenatal care and to investigate the prevalence of
      hemoglobinopathies in pregnant women in Switzerland.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 3, 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>identification of hemoglobinopathies</measure>
    <time_frame>single time point assessment at baseline</time_frame>
    <description>identification of hemoglobinopathies by investigating routine lab samples</description>
  </primary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Hemoglobinopathies</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Review of routine lab data</intervention_name>
    <description>Review of routine lab data from pregnant women (first trimester)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        pregnant women seen at the Frauenklinik at University Hospital Basel
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant women seen at the Frauenklinik at University Hospital Basel

        Exclusion Criteria:

          -  pregnant women with already known hemoglobinopathy

          -  refusal of participation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene Hoesli, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Frauenklinik Universit√§tsspital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriela Amstad Bencaiova, Dr. med</last_name>
    <phone>0041 61 556 5922</phone>
    <email>gabriela.amstad@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irene Hoesli, Prof. Dr.</last_name>
    <phone>0041 61 265 9017</phone>
    <email>irene.hoesli@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Frauenklinik University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Amstad Bencaiova, Dr. med</last_name>
      <phone>+41 61 556 59 22</phone>
      <email>gabriela.amstad@usb.ch</email>
    </contact>
    <investigator>
      <last_name>Franziska Geissler, Dr.med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 17, 2019</study_first_submitted>
  <study_first_submitted_qc>July 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2019</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thalassemia</keyword>
  <keyword>sickle cell anaemia</keyword>
  <keyword>molecular genetic analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemoglobinopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

